02:24 PM EDT, 05/22/2024 (MT Newswires) -- Evotec (EVO) shares rose as much as 2.6% in recent Wednesday trading following the life science company's decision to shut down its gene therapy business in Austria.

The company announced its gene therapy exit to sharpen focus on "core modalities" as it reported a wider net loss and lower revenue for the quarter ended March 31.

Price: 5.15, Change: +0.06, Percent Change: +1.10